Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differentiated thyroid carcinoma in the elderly.

K M van Tol1, E G de Vries, R P Dullaart

  • 1Department of Endocrinology, University Hospital Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands. k.m.van.tol@int.azg.nl

Critical Reviews in Oncology/Hematology
|March 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interpersonal differences in the friction response of skin relate to FTIR measures for skin lipids and hydration.

Colloids and surfaces. B, Biointerfaces·2020
Same author

Friction in the contact between skin and a soft counter material: Effects of hardness and surface finish.

Journal of the mechanical behavior of biomedical materials·2019
Same author

Risk stratification for healthcare planning in women with gestational diabetes mellitus.

The Netherlands journal of medicine·2016
Same author

A tribo-mechanical analysis of PVA-based building-blocks for implementation in a 2-layered skin model.

Journal of the mechanical behavior of biomedical materials·2016
Same author

Limited human epidermal growth factor receptor 2 discordance in metastatic breast cancer patients treated with trastuzumab, a population based study.

European journal of cancer (Oxford, England : 1990)·2014
Same author

Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis.

British journal of cancer·2011
Same journal

Estrobolome and the Endocrine-Microbiome Axis in Breast and Endometrial Carcinogenesis.

Critical reviews in oncology/hematology·2026
Same journal

Remodeling the Immune Microenvironment: Engineering IL-2 Variants to Overcome Clinical Bottlenecks in PD-1 Inhibitor plus Chemotherapy.

Critical reviews in oncology/hematology·2026
Same journal

Neoadjuvant Immunotherapy in Melanoma: From Pathologic Response to Response-Adapted Management.

Critical reviews in oncology/hematology·2026
Same journal

DNA polymerase epsilon catalytic subunit (POLE) in cancer: Implications for tumor biology and therapeutic strategies - A comprehensive review.

Critical reviews in oncology/hematology·2026
Same journal

Long non-coding RNAs in triple-negative breast cancer: emerging drivers of tumor biology, prognosis, and drug resistance.

Critical reviews in oncology/hematology·2026
Same journal

Alternative splicing in breast cancer drug resistance: Mechanisms, therapeutic targeting, and clinical translation.

Critical reviews in oncology/hematology·2026
See all related articles

Differentiated thyroid cancer has an excellent prognosis, but worsens in elderly patients who often present with advanced disease. Optimal therapeutic approaches are crucial for this demographic.

Area of Science:

  • Endocrinology
  • Oncology

Background:

  • Differentiated thyroid cancer prognosis is generally excellent.
  • Elderly patients with differentiated thyroid cancer often have poorer prognostic features, including larger tumors, specific subtypes (follicular, Hürthle cell), extrathyroidal extension, and distant metastases.

Purpose of the Study:

  • To recommend an optimal therapeutic approach for differentiated thyroid cancer in elderly patients.
  • To address challenges associated with radioiodine therapy in older individuals.
  • To emphasize tailored treatment for residual, recurrent, or metastatic disease, irrespective of age.

Main Methods:

  • Standard treatment involves total thyroidectomy, potentially with lymph node dissection.
  • High-dose radioiodine ablation follows surgery.

Related Experiment Videos

  • Management of residual, recurrent, or metastatic disease is individualized.

    • Main Results:

    • Elderly patients present with more advanced disease, necessitating careful therapeutic planning.
    • Radioiodine therapy in the elderly poses challenges, including thyroid hormone withdrawal, side effects of radioactive iodine (131I), and nursing considerations.
    • Lifelong suppressive thyroid hormone therapy is generally well-tolerated in old age without significant long-term side effects.

    Conclusions:

    • An optimized therapeutic strategy is essential for differentiated thyroid cancer in elderly patients.
    • Treatment decisions for advanced disease should not be based on chronological age.
    • Age-appropriate management ensures better outcomes for older individuals with differentiated thyroid cancer.